 Another experimental treatment, TKM-Ebola, started human trials in January 2014, according to its maker, Tekmira Pharmaceuticals. It is used to prevent the spread of the virus and to treat people who are already infected. In tests with primates, the treatment was 100 percent effective in preventing the Ebola virus from spreading, according to Tekmira's documentation. TKM-Ebola has been used to successfully treat humans with the virus.